MCI BLOK 16.ppt
-
Upload
tri-anggun-utami -
Category
Documents
-
view
224 -
download
0
Transcript of MCI BLOK 16.ppt
-
8/12/2019 MCI BLOK 16.ppt
1/24
M
C
I
inimal
ognitive
mpairmentsyafruddin yunus
-
8/12/2019 MCI BLOK 16.ppt
2/24
-
8/12/2019 MCI BLOK 16.ppt
3/24
2 Neurological Function
1. Hard neurological Functunction
Walking,Talking, hearing, balancing,
urine, eating, etc
2. Soft neurological function
neurobehavioural function ( languange,memory, visuospatial, atention, cognitive)
-
8/12/2019 MCI BLOK 16.ppt
4/24
4
STIMULUS INTRINSIK / EKSTRINSIK
FUNGSI LUHUR
SDMKUALITAS
IPTEK / IMTAK
DERAJAT MAHLUK
SURVIVAL
PENDAHULUAN
-
8/12/2019 MCI BLOK 16.ppt
5/24
5
Mahar Mardjono:FL adalah suatu fungs i pada manus ia
yang mengolah dan mengintegrasikanpersepsi secara adekwat
Lezak : . Is an applied science concerned with
the behaviou ral expressiono f brain dy sfunct ion
DEFINISI
-
8/12/2019 MCI BLOK 16.ppt
6/24
Cognitive Function
The best function of neurobehaviour
Sublimation of other neurobehaviour
function
Excecutive functions ; thinking, opinion,
manajemen, solving the problems, wise,
human quality.
-
8/12/2019 MCI BLOK 16.ppt
7/24
Introduction
MCI is a phase of brain decline
High risk of developing Alzheimer (type
dementia )
No uniform definition
Prevalence ; 2 -30% in general population
( Indonesia : no data ) General concept ; cognitive impairment
but not demented.
-
8/12/2019 MCI BLOK 16.ppt
8/24
-
8/12/2019 MCI BLOK 16.ppt
9/24
BRAIN DECLINE SEQUENTIAL
IN ELDERLY
SENESCENCE ( Fisiological )
SENILITY ( In-between group)
DEMENTIA ( Pathological)
-
8/12/2019 MCI BLOK 16.ppt
10/24
SENESCENCE ( Fisiologis)
Signed by forgetfulness.
Kral (1958) : Benign Senescent Forgetfulness (BSF)Crook (1986) :Age Associated Memory Impairment
(AAMI)
Prevalence :
35% in > 65 th age (Lane& Snowdown 1989)
39% in 59 - 60 th & 85% in >80 th age
(Larabe & Crook 1994)
-
8/12/2019 MCI BLOK 16.ppt
11/24
DEMENTIA ( Pathological )
Signed by minimal 3 neurobehavior functionimpairment ( 5 )
Predominant memory impairment
Demented
Ironic : Demented is usual in elderly Is a medical illness
-
8/12/2019 MCI BLOK 16.ppt
12/24
SENILITY ( In-between group)
Signed by actual memory impairment withoutdemented
Mild Cognitive Disorder (MCD) 1993, ICD 10 WHO
Mild Neuro Cognitive Disorder (MNCD) 1994, Levy
Cognitive Impaired Not-Demented (CIND) 1995,Ebly
Mild Conitive Impairment (MCI)1996, Smith
-
8/12/2019 MCI BLOK 16.ppt
13/24
Definition and terminology
Operationalized : the presence of cognitiveimpairment that is not severe enough to meetthe criteria of dementia
More than 40 definitions (2004)
6 major concepts based on : Cognitive complaints only
Mild functional impairment only
Cognitive tests impairment only
Combination of cognitive & tests impairment Combination mild functional & tests impairment
Mild functional tests impairment
-
8/12/2019 MCI BLOK 16.ppt
14/24
MINIMAL COGNITIVE IMPAIRMENT( M.C.I )
Reported for the first time in 1999 in Mayo Clinic
is a trantition phase to dementia
12% in a year , 50% in 3 years ,
80% in 8 yearsCriteria :
- There is an actual memory impairment
reported by another person
- Abnormal impairment for age and education
- Normal ADL
- General cognitive function is normal
- Not demented
-
8/12/2019 MCI BLOK 16.ppt
15/24
NEUROPATHOLOGy/PATHOGENESIS
Brain organic disorders : frontotemporal lobe
atrophy
Microscopic : depend on underlying disease
AlzheimerDementia : senile plaque - neurofibrile
tangles - neuronal loss.
Blood ; amyloid protein,tau protein
Neurotransmiter : Ach preparing disorder
Alzheimer Dementia : Ach
-
8/12/2019 MCI BLOK 16.ppt
16/24
Causes of MCI
Similarly with Alzheimer dementia
MCI is a phase in continuum to Alzheimer
-
8/12/2019 MCI BLOK 16.ppt
17/24
-
8/12/2019 MCI BLOK 16.ppt
18/24
-
8/12/2019 MCI BLOK 16.ppt
19/24
Diagnostic
Clinical sign & symptoms ( neurobehaviorfunction )
Examination
Neurological Supporting examination
Neuropsikiatric tests MMSE, GDS
Radiology
Imaging
Biochemical ( tau protein , Beta amyloid)
-
8/12/2019 MCI BLOK 16.ppt
20/24
-
8/12/2019 MCI BLOK 16.ppt
21/24
NORMATIVE
AGINGM C I
DEMENTIAPATO.AGING
MMSE >24
GDS 1
MMSE 23-17
GDS 2
CONTINUUM
DEGRADASI KONDISI USILA
MMSE
-
8/12/2019 MCI BLOK 16.ppt
22/24
Jenis Tatalaksana
NON FARMAKOLOGIS
FARMAKOLOGIS
Psikososial
Stimulasi Kognisi
- Terapi rekreatif
= Reminisens
= Orientasi nyata
Latihan fisik & otak
ChE-I
Nootropik
Neuroprotektiv
NSAID
Estrogen
Simptomatik lain
-
8/12/2019 MCI BLOK 16.ppt
23/24
Conclusion
MCI is a heterogenous condition
MCI is the risk for Alzheimer ( type dementia)
No standard criteria for MCI
MCI is not related to one spesific disorder
Combination of variable examination may be
useful to diagnose MCI
MCI should be considered as a syndome ratherthan as a disease
The treatment in this phase is very benefit
-
8/12/2019 MCI BLOK 16.ppt
24/24